Beijing Tiantan Biological Products Corp Ltd
SSE:600161

Watchlist Manager
Beijing Tiantan Biological Products Corp Ltd Logo
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Watchlist
Price: 21.26 CNY -3.8% Market Closed
Market Cap: 42B CNY
Have any thoughts about
Beijing Tiantan Biological Products Corp Ltd?
Write Note

Relative Value

The Relative Value of one Beijing Tiantan Biological Products Corp Ltd stock under the Base Case scenario is 32.71 CNY. Compared to the current market price of 21.26 CNY, Beijing Tiantan Biological Products Corp Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
32.71 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
76
vs Industry
46
Median 3Y
9.2
Median 5Y
9.3
Industry
7.7
Forward
7
vs History
96
vs Industry
4
Median 3Y
44.4
Median 5Y
46.7
Industry
22.2
Forward
30.6
vs History
93
vs Industry
8
Median 3Y
29.4
Median 5Y
33.5
Industry
22.3
vs History
53
vs Industry
4
Median 3Y
36.8
Median 5Y
41.5
Industry
25.5
vs History
84
vs Industry
17
Median 3Y
4.8
Median 5Y
5.4
Industry
2.5
vs History
76
vs Industry
39
Median 3Y
8.6
Median 5Y
8.8
Industry
7.8
Forward
6.4
vs History
88
vs Industry
26
Median 3Y
17.4
Median 5Y
18.1
Industry
9
vs History
95
vs Industry
4
Median 3Y
27.4
Median 5Y
28.5
Industry
3.9
Forward
15.9
vs History
95
vs Industry
5
Median 3Y
27.4
Median 5Y
28.5
Industry
3.6
Forward
21.9
vs History
93
vs Industry
8
Median 3Y
26.8
Median 5Y
31.4
Industry
5.2
vs History
55
vs Industry
4
Median 3Y
32.9
Median 5Y
37.7
Industry
3.3
vs History
82
vs Industry
33
Median 3Y
4
Median 5Y
4.7
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Beijing Tiantan Biological Products Corp Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
42B CNY 7.9 33.1 19.6 19.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.4B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 11 -243 24.2 25.5
US
Gilead Sciences Inc
NASDAQ:GILD
112.5B USD 4 892.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.3B USD 6 17.7 16.1 17.9
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average P/E: 179.2
33.1
73%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -243
42%
US
Gilead Sciences Inc
NASDAQ:GILD
892.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average EV/EBITDA: 17.6
19.6
99%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
Beijing Tiantan Biological Products Corp Ltd
SSE:600161
Average EV/EBIT: 22.1
19.6
50%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top